<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="2-part\PMC6940900\results\search\drugs\results.xml">
  <result pre="respectively, which showed that NC-5 had a great advantage over" exact="oseltamivir" post="in drug-resistant virus infections. The 50% cytotoxic concentration (CC50)"/>
  <result pre="and Glu119 [5]. Benefitting from alkylation and guanidylation of the" exact="oseltamivir" post="C-5 amino acid and the same transformations at position"/>
  <result pre="reported to show potent antiviral activity [15]. The analogs of" exact="oseltamivir" post="and zanamivir that possess a triazole substituent had been"/>
  <result pre="show potent antiviral activity [15]. The analogs of oseltamivir and" exact="zanamivir" post="that possess a triazole substituent had been reported to"/>
  <result pre="than 480 μM. For oseltamivir-resistant strains, the inhibition rates of" exact="oseltamivir" post="at 1 nM were less than 2% compared with"/>
  <result pre="considerable protective effect. H1N1, H1N1-H275Y and H3N2 were tested with" exact="oseltamivir" post="carboxylate (OC) as a control. NC-5 (10–160 μM) showed"/>
  <result pre="microscopic observation, which detected a far lower CPE than the" exact="dimethyl sulfoxide" post="(DMSO) control and the OC-treated cells (Figure 3E). NC-5"/>
  <result pre="subsequent studies. Compared to the two widely used anti-influenza drugs," exact="zanamivir" post="and oseltamivir, BANA-206 and NC-5 are achiral molecules exhibiting"/>
  <result pre="Chinese Academy of Sciences. 4.2. Compounds Oseltamivir phosphate (OS) and" exact="oseltamivir" post="carboxylate (OC) were purchased from MedChem Express (Shanghai, China)."/>
  <result pre="later, NC-5 (50 mg/kg/d, 75 mg/kg/d and 100 mg/kg/d) or" exact="oseltamivir" post="phosphate (OS) (100 mg/kg/d) was given twice daily for"/>
  <result pre="NC-5 (10 μM, 40 μM and 80 μM), DMSO and" exact="ribavirin" post="(RBV) (40 μM). The cell lysates were collected after"/>
  <result pre="DMEM Dulbecco’s modified Eagle’s medium CHO-K1 Chinese hamster ovary OS" exact="oseltamivir" post="phosphate OC oseltamivir carboxylate RBV ribavirin CPE cytopathic effect"/>
  <result pre="Eagle’s medium CHO-K1 Chinese hamster ovary OS oseltamivir phosphate OC" exact="oseltamivir" post="carboxylate RBV ribavirin CPE cytopathic effect EC50 50% effective"/>
  <result pre="Chinese hamster ovary OS oseltamivir phosphate OC oseltamivir carboxylate RBV" exact="ribavirin" post="CPE cytopathic effect EC50 50% effective concentrations CC50 50%"/>
  <result pre="acylthiourea derivatives possessing broad-spectrum antiviral activityBioorg. Med. Chem. Lett2012224263427210.1016/j.bmcl.2012.05.03522664128 13.TarbetE.B.HamiltonS.VollmerA.H.LuttickA.NgW.C.PryorM.HurstB.L.CrawfordS.SmeeD.F.TuckerS.P.A" exact="zanamivir" post="dimer with prophylactic and enhanced therapeutic activity against influenza"/>
  <result pre="experiments, *p &amp;lt;0.05, **p &amp;lt;0.01, ***p &amp;lt;0.001, compared with the" exact="dimethyl sulfoxide" post="(DMSO) control. Figure 3 Inhibitory effect of NC-5 on"/>
  <result pre="and ten mice in each group received placebo, NC-5 or" exact="oseltamivir" post="phosphate (OS) twice daily for 5 days. (A) Survival"/>
  <result pre="ten mice in each group received a placebo, NC-5 or" exact="oseltamivir" post="phosphate (OS) twice daily for 5 days. (A) Survival"/>
  <result pre="(CPE) reduction assays. a substituent group on the triazole. b" exact="oseltamivir" post="carboxylate. c not detected."/>
 </snippets>
</snippetsTree>
